Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer

Gynecological Endocrinology

Volumn 18, Issue 6, 2004, Pages 335-340

  Onagawa, T ^a   Shibahara, H ^a   Ayustawati, ^a   Machida, S ^a   Hirano, Y ^a   Hirashima, C ^a   Takamizawa, S ^a   Suzuki, M ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Follicle Stimulating Hormone; Gonadotropin; IVF ET; OHSS; Ovarian Reserve

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; NAFARELIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY DISEASE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; OOCYTES; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 3142696385     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/0951359042000196303     Document Type: Article

References (28)

1. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61
2. Keay SD, Liversedge NH, Mathur RS, et al. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-7
3. Tarlatzis BC, Zepiridis L, Grimbizis G, et al. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76
4. Scott RT, Toner JP, Muasher SL, et al. Follicle-stimulating hormone levels on cycle day 3 are predictive of in-vitro fertilization outcome. Fertil Steril 1989;51:651-4
5. Ebrahim A, Rienhardt G, Morris S, et al. Follicle-stimulating hormone levels on cycle day 3 predict ovulation stimulation response. J Assist Reprod Genet 1993;10:130-6
6. Huyser C, Fouri FLR, Pentz J, et al. The predictive value of basal follicle-stimulating and growth hormone levels as determined by immunofluorometry during assisted reproduction. J Assist Reprod Genet 1995;12:244-51
7. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-4
8. Sharif K, Elgendy M, Lashen H, et al. Age and basal follicle stimulating hormone as predictors of in vitro fertilization outcome. Br J Obstet Gynaecol 1998;105:107-12
9. Bancsi LFJMM, Huijs AM, Den Oude CT, et al. Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril 2000;73:552-7
10. Smotrich DB, Widra EA, Gindorff PR, et al. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136-40
11. Seifer DB, Lambert-Messerlian G, Hogan JW, et al. Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997;67:110-14
12. Corson SL, Gutman J, Batzet FR, et al. Inhibin B as a test of ovarian reserve for infertile women. Hum Reprod 1999;14:2818-21
13. Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999;14:409-15
14. Tamura H, Nakamura Y, Takiguchi S, et al. Value of serum FSH determination on day 2 of the IVF cycle induced by GnRH-agonist suppression for prediction of ovarian response. Jpn J Fertil Steril 1999;44:299-303
15. Shibahara H, Naito S, Hasegawa A, et al. Evaluation of sperm fertilizing ability using the Sperm Quality Analyzer. Int J Androl 1997;20:112-17
16. Shibahara H, Mitsuo M, Inoue M, et al. Relationship between human in-vitro fertilization and intracytoplasmic sperm injection and the zona-free hamster egg penetration test. Hum Reprod 1998;13:1928-32
17. Shibahara H, Suzuki T, Tanaka Y, et al. Establishment and application of criteria for the elective transfer of two good-quality embryos to reduce high-order multiple pregnancies. Reprod Med Biol 2002;1:23-9
18. Geber S, Ferreira DP, Spyer Prates LF, et al. Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reprod Biomed Online 2002;5:162-6
19. Ho HY, Lee RK, Hwu YM, et al. Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation. J Assist Reprod Genet 2002;19:507-11
20. Wardle PG, Mitchell JD, McLaughlin EA, et al. Endometriosis and ovulatory disorder: reduced fertilization in vitro compared with tubal and unexplained infertility. Lancet 1985;3:236-9
21. Keay SD, Liversedge NH, Jenkins JM. Could ovarian infection impair ovarian response to gonadotrophin stimulation? Br J Obstet Gynaecol 1998;105:252-3
22. van Kasteren YM, von Blomberg M, Hoek A, et al. Incipient ovarian failure and premature ovarian failure show the same immunological profile. Am J Reprod Immunol 2000;43:359-66
23. Lee DW, Grasso P, Dattatreyamurty B, et al. Purification of a high molecular weight follicle-stimulating hormone receptor-binding inhibitor from human follicular fluid. J Clin Endocrinol Metab 1993;77:163-8
24. Pellicer A, Ballester MJ, Serrano MD, et al. Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels. Hum Reprod 1994;9:806-11
25. Wheatcroft NJ, Rogers CA, Metcalfe RA, et al. Is subclinical ovarian failure an autoimmune disease? Hum Reprod 1997;12:244-9
26. Tsunoda T, Shibahara H, Hirano Y, et al. Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine. Gynecol Endocrinol 2003;17:281-6
27. Koike T, Araki S, Minakami H, et al. Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome. Hum Reprod 2000;15:113-17
28. Takamizawa S, Shibahara H, Taneichi A, et al. Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt. Am J Reprod Immunol 2002;47:25-30